SubPrime Mortgage Fraud & Its Effect on Institutional Investors
Houssiere, Durant, & Houssiere LLP is actively investigating investment banks and ratings agencies that facilitated
transactions involving Auction Rate, Mortgage and other misrepresented securities issued over the past few years.
Recent federal probes into the subprime mortgage collapse and resulting decrease in investor confidence and
liquidity has gained nationwide attention, spurring the formation of specialized teams of attorneys to meet the
oncoming demand for both criminal and civil representation.
The current mortgage crisis, brought about by the
flood of the market with risky loans failing at an increasingly alarming rate has already had a significant
impact upon the creditworthiness of many corporations, municipalities and institutions. These institutions
require civil trial attorneys skilled in litigating mass tort and commercial claims and corporate fraud cases, as well as highly
specialized experts who are knowledgeable in banking and securities regulation law.
Our firm has assembled
a unique and experienced team to address the individual details of potential claims of our commercial litigation
clients. Our established trial lawyers are working in collaboration with SEC-registered investment banking specialists
and highly reputable and knowledgeable commercial securities transaction attorneys with offices in Houston and
on Wall Street. This professional collaboration will allow the firm to efficiently analyze and prosecute specific institutions’
portfolio losses to identify damages directly caused by accounting fraud, insider trading and deceptive sales
practices.
If you are a corporate investor experiencing loss due to these problems, you should
contact Houssiere, Durant, & Houssiere LLP to discuss possible civil claims for prompt and
efficient resolution.
Multiple Sclerosis medicine may harm the liver
Biogen Idec Inc. and Elan Corp.'s multiple sclerosis medicine Tysabri may harm the liver within six days of
the first dose, U.S. regulators said, urging doctors to warn patients about the risk. Patients should stop
taking Tysabri if they develop jaundice or other symptoms, according to a letter this month to doctors from
the drugmakers and posted today on the Food and Drug Administration's Web site. The companies said not all
doctors were aware of the risk, added to prescribing information in January when the drug was approved for
an expanded use. If you or someone you know has taken Tysabri, you or they may be entitled to monetary damages.
Contact us for a free consultation.
Article:
Biogen's Tysabri May Cause Liver Injury, U.S. Says
Adverse Medical Reactions to ADCON-L
ADCON-L is a drug designed to inhibit post-surgical scarring and adhesions following lumbar surgery.
Gliatech, the manufacturer of ADCON-L, faced six federal misdemeanor charges of providing false or
incomplete information to the FDA. On April 18, 2002, the company plead guilty to these charges and
received the maximum fine of $1.2 million. Though the company received reports of adverse medical
reactions from use of the back surgery gel, ADCON-L, they failed to report these problems within 30
days to the FDA. Gliatech also plead guilty to falsely misrepresenting the test results to the FDA.
If you or a family member have used ADCON-L and suffered any adverse medical reactions, please
contact HD&H for a free case evaluation.
NHTSA probes reports of Passat engine fires
The government has upgraded an investigation into the Volkswagen Passat after receiving dozens of reports of engine fires. The National
Highway Traffic Safety Administration (NHTSA) said Tuesday there had been 78 reports of engine fires and two injuries. The investigation
is focused on about 345,000 Passat sedans from the 2000-2003 model year.
Crib deaths prompt massive recall
 Updated Bulletins April 2008
The following bulletins have been added or updated recently! Check them out.
Click here for the Bulletins index page.
|
